IBDEI0QN ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13147,0)
 ;;=V25.9^^87^830^4
 ;;^UTILITY(U,$J,358.3,13147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13147,1,4,0)
 ;;=4^V25.9
 ;;^UTILITY(U,$J,358.3,13147,1,5,0)
 ;;=5^Contraceptive Management
 ;;^UTILITY(U,$J,358.3,13147,2)
 ;;=^276356
 ;;^UTILITY(U,$J,358.3,13148,0)
 ;;=V65.40^^87^830^5
 ;;^UTILITY(U,$J,358.3,13148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13148,1,4,0)
 ;;=4^V65.40
 ;;^UTILITY(U,$J,358.3,13148,1,5,0)
 ;;=5^Counseling NOS
 ;;^UTILITY(U,$J,358.3,13148,2)
 ;;=^87449
 ;;^UTILITY(U,$J,358.3,13149,0)
 ;;=V58.83^^87^830^6
 ;;^UTILITY(U,$J,358.3,13149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13149,1,4,0)
 ;;=4^V58.83
 ;;^UTILITY(U,$J,358.3,13149,1,5,0)
 ;;=5^Encounter for Therapeutic Drug Monitor
 ;;^UTILITY(U,$J,358.3,13149,2)
 ;;=^322076
 ;;^UTILITY(U,$J,358.3,13150,0)
 ;;=V18.51^^87^830^18
 ;;^UTILITY(U,$J,358.3,13150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13150,1,4,0)
 ;;=4^V18.51
 ;;^UTILITY(U,$J,358.3,13150,1,5,0)
 ;;=5^Family h/o Colonic Polyps
 ;;^UTILITY(U,$J,358.3,13150,2)
 ;;=^334209
 ;;^UTILITY(U,$J,358.3,13151,0)
 ;;=V18.59^^87^830^22
 ;;^UTILITY(U,$J,358.3,13151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13151,1,4,0)
 ;;=4^V18.59
 ;;^UTILITY(U,$J,358.3,13151,1,5,0)
 ;;=5^Family h/o GI Problems
 ;;^UTILITY(U,$J,358.3,13151,2)
 ;;=^334210
 ;;^UTILITY(U,$J,358.3,13152,0)
 ;;=V68.09^^87^830^31
 ;;^UTILITY(U,$J,358.3,13152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13152,1,4,0)
 ;;=4^V68.09
 ;;^UTILITY(U,$J,358.3,13152,1,5,0)
 ;;=5^Form Completion
 ;;^UTILITY(U,$J,358.3,13152,2)
 ;;=^335321
 ;;^UTILITY(U,$J,358.3,13153,0)
 ;;=V10.51^^87^830^39
 ;;^UTILITY(U,$J,358.3,13153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13153,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,13153,1,5,0)
 ;;=5^Personal h/o Bladder Cancer
 ;;^UTILITY(U,$J,358.3,13153,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,13154,0)
 ;;=V10.3^^87^830^40
 ;;^UTILITY(U,$J,358.3,13154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13154,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,13154,1,5,0)
 ;;=5^Personal h/o Breast Cancer
 ;;^UTILITY(U,$J,358.3,13154,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,13155,0)
 ;;=V10.41^^87^830^41
 ;;^UTILITY(U,$J,358.3,13155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13155,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,13155,1,5,0)
 ;;=5^Personal h/o Cervical Cancer
 ;;^UTILITY(U,$J,358.3,13155,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,13156,0)
 ;;=V10.05^^87^830^42
 ;;^UTILITY(U,$J,358.3,13156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13156,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,13156,1,5,0)
 ;;=5^Personal h/o Colon Cancer
 ;;^UTILITY(U,$J,358.3,13156,2)
 ;;=^295207
 ;;^UTILITY(U,$J,358.3,13157,0)
 ;;=V10.03^^87^830^47
 ;;^UTILITY(U,$J,358.3,13157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13157,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,13157,1,5,0)
 ;;=5^Personal h/o Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,13157,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,13158,0)
 ;;=V10.21^^87^830^55
 ;;^UTILITY(U,$J,358.3,13158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13158,1,4,0)
 ;;=4^V10.21
 ;;^UTILITY(U,$J,358.3,13158,1,5,0)
 ;;=5^Personal h/o Laryngeal Cancer
 ;;^UTILITY(U,$J,358.3,13158,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,13159,0)
 ;;=V10.60^^87^830^56
 ;;^UTILITY(U,$J,358.3,13159,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13159,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,13159,1,5,0)
 ;;=5^Personal h/o Leukemia
 ;;^UTILITY(U,$J,358.3,13159,2)
 ;;=^295231
 ;;^UTILITY(U,$J,358.3,13160,0)
 ;;=V10.11^^87^830^57
 ;;^UTILITY(U,$J,358.3,13160,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13160,1,4,0)
 ;;=4^V10.11
